pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,366 catalysts · 3,045 8k filing · 571 earnings · 249 grant · 179 approval · 172 phase 2 completion · 133 drug shortage

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 75 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 17 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-04-02×clear all
type
  • 8k filing3,045
  • earnings571
  • grant249
  • approval179
  • phase 2 completion172
  • drug shortage133
  • device 510k116
  • phase 1 completion73
  • phase 2 initiation62
  • device pma59
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 30, 2026

    50
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalBoehringer Ingelheim Corp

    Sponsor: DR REDDYS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 2, 2026approval131d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 2, 2026approval131d agoEYLEA HD (AFLIBERCEPT) — FDA approvalEYLEA HD

    Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION

    full page →EYLEA HD →fda approvals ↗
    ›Apr 2, 2026approval131d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 2, 2026approval131d agoPALIPERIDONE — FDA approvalEskayef Pharmaceuticals Ltd

    Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: CIPLA. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 2, 2026approval131d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: STRIDES PHARMA. Form: CAPSULE. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: DEXCEL. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 2, 2026approval131d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Apr 2, 2026approval131d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

    Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL

    full page →ACETAZOLAMIDE →fda approvals ↗
    ›Apr 2, 2026approval131d agoNINTEDANIB ESYLATE — FDA approvalOfev

    Sponsor: APOTEX. Form: CAPSULE. Route: ORAL

    full page →Ofev →fda approvals ↗
    ›Apr 2, 2026device 510k131d agoMedical Brands Laboratories B.V. — Advanced Cryo Skin Tag Remover (Advanced Skin Tag Remover) (510k cleared)

    Product code: GEH. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoIcu Medical, Inc. — LifeShield Infusion Safety Software Suite (510k cleared)ICU MEDICAL INC/DE

    Product code: PHC. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoShalby Advanced Technologies, Inc. Dba Consensus Orthopedics — Tahoe Unicondylar Knee System with TiNbN Overcoat (510k cleared)

    Product code: HSX. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoBeijing L&Z Medical Technology Development Co., Ltd. — Disposable Infusion Bag for Parenteral Nutrition (510k cleared)

    Product code: KPE. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoVerge Medical, Inc. — FLASH Flex™ Aorto-Ostial Angioplasty System (510k cleared)VYCOR MEDICAL INC

    Product code: LOX. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoChengdu Cryo-Push Medical Technology Co.,Ltd — Cryopush Cold Compression Device (A02-P-001) (510k cleared)

    Product code: IRP. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoEl.En S.P.A. — SPECCHIO (510k cleared)

    Product code: PBX. Advisory committee: General, Plastic Surgery. Type: Special

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoMiracell Co., Ltd. — SMART M-CELL PRP Concentration System (510k cleared)

    Product code: QBV. Advisory committee: Clinical Chemistry. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoBecton, Dickinson and Company — Onclarity™ Self-Collection Kit (510k cleared)BECTON DICKINSON & CO

    Product code: SEP. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoMiracell Co., Ltd. — SMART M-CELL Bone Marrow Concentration System (510k cleared)

    Product code: QBV. Advisory committee: Clinical Chemistry. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoXuzhou Yongkang Electronic Science Technology Co., Ltd. — Wireless Probe Type Ultrasound Scanner (510k cleared)

    Product code: IYN. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoJeil Medical Corporation — Leforte MMF System (510k cleared)

    Product code: JEY. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoBecton Dickinson Infusion Therapy Systems, Inc. — BD Insyte™ IV Catheter (510k cleared)

    Product code: FOZ. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoRoche Diagnostics — Tina-quant Cardiac high sensitivity CRP III (510k cleared)Dawn Sea Therapeutics

    Product code: NQD. Advisory committee: Immunology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device 510k131d agoGenoray Co., Ltd. — BELLIGER ACE (510k cleared)

    Product code: OWB. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 2, 2026device pma131d agoEuclid Vision Corporation — Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear and Euclid Orthokeratology (tisilfocon A) Contact (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NUU. Advisory committee: OP. Decision: OK30

    full page →fda device pma ↗
    ›Apr 2, 2026device pma131d agoABBOTT MEDICAL — HeartMate 3™ Left Ventricular Assist System (LVAS) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: DSQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Apr 2, 2026device pma131d agoInstylla, Inc. — Embrace Hydrogel Embolic System (HES) (PMA supplement)

    Supplement type: Real-Time Process. Product code: QVG. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 2, 2026device pma131d agoBecton, Dickinson and Company — BD Onclarity HPV Assay (PMA supplement)BECTON DICKINSON & CO

    Supplement type: Normal 180 Day Track. Product code: MAQ. Advisory committee: MI. Decision: APPR

    full page →fda device pma ↗
    ›Apr 2, 2026device pma131d agoBecton, Dickinson and Company — BD Onclarity HPV Assay (PMA supplement)BECTON DICKINSON & CO

    Supplement type: Normal 180 Day Track No User Fee. Product code: MAQ. Advisory committee: MI. Decision: APPR

    full page →fda device pma ↗
    ›Apr 2, 2026device pma131d agoBoston Scientific Corp — EPIC Self-Expanding Stent System (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: NIO. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Apr 2, 2026device pma131d agoBiotronik, Inc. — Solia CSP S Leads (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: NVN. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 2, 2026device pma131d agoEndospan , Ltd. — NEXUS Aortic Arch Stent Graft System (PMA)

    Product code: SDZ. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 2, 2026device pma131d agoMedtronic, Inc. — Sphere-9 Catheter; Tubing Set; Extension Cable (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: QZI. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Apr 2, 2026grant131d agoYALE UNIVERSITY — Novel Treg inactivating approach for cancer immunotherapy via targeted protei...

    CA grant. $482,312. PI: Wei Hu

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoALBERT EINSTEIN COLLEGE OF MEDICINE — Interrogating Erythroid Differentiation and BCL-XL Axis in TP53-mutated Acute...Albert Einstein College of Medicine

    CA grant. $442,816. PI: Hussein Abbas

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoUNIVERSITY OF CALIFORNIA SANTA CRUZ — Exploration of the bacterial polyadenylase PAP I as an antimicrobial drug target

    AI grant. $430,375. PI: Victoria Auerbuch Stone

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoRESEARCH INST NATIONWIDE CHILDREN'S HOSP — Genetically and metabolically defining high-risk neuroblastoma to exploit eff...

    CA grant. $608,558. PI: Ruoning Wang

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoLA JOLLA INSTITUTE FOR IMMUNOLOGY — Human upper airway immune memory kinetics and durability against respiratory ...Dawn Sea Therapeutics

    AI grant. $159,300. PI: Sydney Ilima Ramirez

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoUNIVERSITY OF CHICAGO — Dissecting the intrinsic role of SLC4A2 in the development of liver inflammat...

    AI grant. $164,000. PI: Axel Rolando Concepcion Gonzalez

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoLOYOLA UNIVERSITY CHICAGO — Anti-inflammatory effects of reverse transcriptase inhibitors during bacteria...AimMax Therapeutics Inc

    AI grant. $158,800. PI: Karthik Hullahalli

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoUNIVERSITY OF CHICAGO — Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus

    AR grant. $582,695. PI: Jill P Buyon

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Cellular and circuit mechanisms underlying the generation, regulation, and fl...

    MH grant. $126,900. PI: Lynn Yap

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoUNIVERSITY OF CHICAGO — Investigating the immunomodulatory role of the Nonclassical MHC Molecule HLA-...

    AI grant. $818,457. PI: Erin June Adams

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Neutralizing antibody pressure on the evolution of SARS-CoV-2 variants."

    AI grant. $194,160. PI: Ian Alexander Mellis

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoFRED HUTCHINSON CANCER CENTER — Modeling SARS-CoV-2 variant emergence from immunocompromised hosts

    AI grant. $161,946. PI: Katherine Owens

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoROCHESTER INSTITUTE OF TECHNOLOGY — Surveillance of antibiotic resistance in natural commensal Neisseria populati...

    AI grant. $561,410. PI: Crista Burke Wadsworth

    full page →nih reporter ↗
    ›Apr 2, 2026grant131d agoEMORY UNIVERSITY — The Role of Clonal Hematopoiesis in Lung Cancer: Immune Dysregulation and The...Emory University

    CA grant. $646,181. PI: Janghee Woo

    full page →nih reporter ↗
    ← prev
    page 1 of 88
    next →
    $BDX179.63+1.57%
    $REGN808.05+3.02%
    $BDX179.63+1.57%
    $MDT89.41+2.58%
    $ICUI182.42-1.16%
    $VYCO0.06600.00%
    $BSX50.46+2.33%
    $BDX179.63+1.57%